Výsledky vyhledávání - "S. A. Ringel"

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis

Autor: Mark A. Ross, L. A. Young, Carmel Armon, Gareth Parry, S. P. Ringel, John Ravits, Deborah F. Gelinas, Richard J. Barohn, Mark B. Bromberg, Robert G. Miller, Dan H. Moore, W. W. Bryan, Michelle Mendoza, H. E. Neville, Jack H. Petajan

Publikováno v: Neurology. 47:1383-1388

We designed a phase II trial to evaluate the efficacy of gabapentin in slowing the rate of decline in muscle strength of patients with amyotrophic lateral sclerosis (ALS) and to assess safety and tolerability. Gabapentin (800 mg) or placebo was admin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31b54ff3070944325aa16d3c0f11d9a4
https://doi.org/10.1212/wnl.47.6.1383

Zobrazit plný text záznamu

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group

Autor: R G, Miller, D, Moore, L A, Young, C, Armon, R J, Barohn, M B, Bromberg, W W, Bryan, D F, Gelinas, M C, Mendoza, H E, Neville, G J, Parry, J H, Petajan, J M, Ravits, S P, Ringel, M A, Ross

Publikováno v: Neurology. 47(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::283ce82be1d88d65ddd72ec9b0479c11
https://pubmed.ncbi.nlm.nih.gov/8960715

Zobrazit plný text záznamu

Neurologists--1990

Autor: S. P. Ringel

Publikováno v: Neurology. 41(12)

The American Medical Association Physician Masterfile for 1990 contains 13,705 physicians who consider neurology their primary, secondary, or tertiary specialty. Of these, 7,036 are board certified and 10,065 designated neurology as their primary spe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdd04a7b5853f4a616d2ff229dd5e52
https://pubmed.ncbi.nlm.nih.gov/1641178

Zobrazit plný text záznamu

The relationship of age to outcome in myasthenia gravis

Autor: R. B. Rutherford, S. P. Ringel, M. Ansher, S. Horan, D. H. Donaldson

Publikováno v: Neurology. 40:786-786

This study, a retrospective review of 165 patients with myasthenia gravis, compares the course of the disease for patients with onset before 50 and at or after 50. There were no significant differences between age groups for presenting symptoms, but

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48f13a9ec160215b76b0d2bc33f3b24
https://doi.org/10.1212/wnl.40.5.786

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání